1. |
Caceres JA, Goldstein JN. Intracranial hemorrhage. Emerg Med Clin North Am, 2012, 30(3): 771-794.
|
2. |
Naidech AM. Intracranial hemorrhage. Am J Respir Crit Care Med, 2011, 184(9): 998-1006.
|
3. |
中華醫學會神經病學分會, 中華醫學會神經病學分會腦血管病學組. 中國腦出血診治指南(2019). 中華神經科雜志, 2019, 52(12): 994-1005.
|
4. |
何菁, 王芳, 熊璐璐, 等. 腦卒中并發靜脈血栓栓塞癥的發生情況及危險因素分析. 四川大學學報(醫學版), 2023, 54(3): 638-641.
|
5. |
張萍. 神經重癥患者危重病情的精準量化評估. 武漢: 華中科技大學, 2018.
|
6. |
Liu S, Wang Y, Gao B, et al. A nomogram for predicting venous thromboembolism in critically ill patients with primary intracerebral hemorrhage. World Neurosurg, 2022, 157: e301-e307.
|
7. |
Chu Q, Liao L, Wei W, et al. Venous thromboembolism in ICU patients with intracerebral hemorrhage: risk factors and the prognosis after anticoagulation therapy. Int J Gen Med, 2021, 14: 5397-5404.
|
8. |
杜偉, 周輝, 魏新亭. AHA/ASA《自發性腦出血診療指南(2022 版)》解讀. 中華神經醫學雜志, 2023, 22(3): 217-221.
|
9. |
Dastur CK, Yu W. Current management of spontaneous intracerebral haemorrhage. Stroke Vasc Neurol, 2017, 2(1): 21-29.
|
10. |
van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol, 2010, 9(2): 167-176.
|
11. |
中華醫學會呼吸病學分會肺栓塞與肺血管病學組, 中國醫師協會呼吸醫師分會肺栓塞與肺血管病工作委員會, 全國肺栓塞與肺血管病防治協作組. 肺血栓栓塞癥診治與預防指南. 中華醫學雜志, 2018, 98(14): 1060-1087.
|
12. |
倪瑩瑩, 王首紅, 宋為群, 等. 神經重癥康復中國專家共識(下). 中國康復醫學雜志, 2018, 33(3): 264-268.
|
13. |
中華醫學會重癥醫學分會. 重癥監護病房患者深靜脈血栓形成預防指南. 中國危重病急救醫學, 2009, 21(9): 514-517.
|
14. |
陳穎. 危重癥患者下肢深靜脈血栓影響因素分析及風險預測模型構建. 青島: 青島大學, 2021.
|
15. |
宮蓓蕾, 許啟霞, 龐穎穎, 等. 靜脈血栓栓塞癥患者臨床特征: 10 年 177 例病例分析. 中華危重病急救醫學, 2019, 31(4): 453-457.
|
16. |
Malone PC, Agutter PS. The aetiology of deep venous thrombosis. QJM, 2006, 99(9): 581-593.
|
17. |
高亮, 陳宋育. 美國神經重癥學會預防神經重癥患者靜脈血栓栓塞指南的解讀. 中華神經創傷外科電子雜志, 2016, 2(5): 261-270.
|
18. |
袁春艷, 彭衛平, 鄧娟娟. 腦出血老年患者術后發生靜脈血栓栓塞的危險因素. 吉林醫學, 2023, 44(7): 1985-1987.
|
19. |
Dong C, Li Y, Ma Z. Venous thromboembolism after spontaneous intracerebral hemorrhage and the status quo of anticoagulation in this population: a retrospective casecontrol study from a tertiary hospital in China. Clin Neurol Neurosurg, 2023, 231: 107839.
|
20. |
Miao L, Shi J, Yu H, et al. Studies on atrial fibrillation and venous thromboembolism in the past 20 years: a bibliometric analysis via CiteSpace and VOSviewer. J Am Heart Assoc, 2023, 12(17): e029810.
|
21. |
Melmed KR, Boehme A, Ironside N, et al. Respiratory and blood stream infections are associated with subsequent venous thromboembolism after primary intracerebral hemorrhage. Neurocrit Care, 2021, 34(1): 85-91.
|
22. |
王榮榮, 周乾宇, 郭園麗, 等. 腦卒中患者靜脈血栓栓塞癥風險預測模型的構建及驗證. 中華疾病控制雜志, 2023, 27(10): 1161-1166.
|
23. |
石瓊婭, 周立宇, 張嬌, 等. 預測老年自發性腦出血患者深靜脈血栓——基于 MIMIC-Ⅳ數據庫回顧性分析. 臨床神經外科雜志, 2023, 20(3): 327-331.
|
24. |
Koch V, Biener M, Müller-Hennessen M, et al. Diagnostic performance of D-dimer in predicting venous thromboembolism and acute aortic dissection. Eur Heart J Acute Cardiovasc Care, 2021, 10(5): 559-566.
|
25. |
Wolberg AS, Sang Y. Fibrinogen and factor XIII in venous thrombosis and thrombus stability. Arterioscler Thromb Vasc Biol, 2022, 42(8): 931-941.
|
26. |
Ding J, Yue X, Tian X, et al. Association between inflammatory biomarkers and venous thromboembolism: a systematic review and meta-analysis. Thromb J, 2023, 21(1): 82.
|
27. |
Wang G, Zhao W, Zhao Z, et al. Leukocyte as an independent predictor of lower-extremity deep venous thrombosis in elderly patients with primary intracerebral hemorrhage. Frontiers in Neurol, 2022, 13: 899849.
|
28. |
Spasi? I, Ubavi? M, ?umarac Z, et al. Influence of lipid metabolism disorders on venous thrombosis risk. J Med Biochem, 2021, 40(3): 245-251.
|
29. |
Ren W, Huang Q, Fan K, et al. Uric acid played a role in the association between gender and deep vein thrombosis in patients with stroke. Nutr Metab Cardiovasc Dis, 2021, 31(9): 2700-2706.
|
30. |
湯廳均, 張翔, 耿保偉, 等. 腦出血術后下肢深靜脈血栓形成的臨床特點及危險因素. 血管與腔內血管外科雜志, 2023, 9(2): 250-253, 256.
|
31. |
Kelly J, Hunt BJ, Lewis RR, et al. Dehydration and venous thromboembolism after acute stroke. QJM, 2004, 97(5): 293-296.
|
32. |
張紅玲, 許佑冬, 劉正東. 急性腦出血患者 ICU 期間下肢深靜脈血栓發生的危險因素分析. 中華神經醫學雜志, 2020, 19(5): 488-492.
|
33. |
林鴻輝, 田原卿. 腦出血患者在 ICU 期間下肢深靜脈血栓形成的影響因素及中西醫結合預防策略. 黑龍江醫藥, 2023, 36(3): 607-610.
|
34. |
Hallan DR, Simion C, Rizk E. Early versus late tracheostomy in spontaneous intracerebral hemorrhage. Cureus, 2022, 14(4): e24059.
|
35. |
郝廣志, 董玉書, 張冰瑩, 等. 基于 LASSO-logistic 回歸構建腦出血術后下肢靜脈血栓的風險預測模型. 中華神經外科疾病研究雜志, 2024, 18(4): 1-6.
|
36. |
Benincasa G, Costa D, Infante T, et al. Interplay between genetics and epigenetics in modulating the risk of venous thromboembolism: a new challenge for personalized therapy. Thromb Res, 2019, 177: 145-153.
|
37. |
姚漪婷. 靜脈血栓栓塞癥遺傳特征分析. 廣州: 廣州醫科大學, 2023.
|
38. |
周佳, 嚴靜, 李莉. 重癥醫學科患者深靜脈血栓形成預防現狀的研究進展. 中華重癥醫學電子雜志(網絡版), 2020, 6(3): 314-317.
|
39. |
Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon, 2005, 51(2/3): 70-78.
|
40. |
周鑫飛, 嚴靜. 靜脈血栓栓塞癥風險評估模型在重癥監護室中的應用. 心腦血管病防治, 2022, 22(6): 66-70.
|
41. |
劉陽. Caprini 風險評估模型對高血壓腦出血住院患者靜脈血栓栓塞癥的預測價值. 慢性病學雜志, 2022, 23(12): 1817-1820.
|
42. |
張亞斌, 馬丹, 李蕊, 等. 危重癥患者靜脈血栓栓塞癥風險預測模型的研究進展. 中國護理管理, 2022, 22(7): 1116-1120.
|
43. |
Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost, 2010, 8(11): 2450-2457.
|
44. |
李巍, 王莉莉. Padua 血栓評估模型對腦卒中患者靜脈血栓栓塞癥的評估價值. 中國現代神經疾病雜志, 2020, 20(8): 727-732.
|
45. |
余靜, 田鵬, 李玲. Padua 血栓評估模型臨床使用現狀及分析. 護理實踐與研究, 2021, 18(23): 3531-3534.
|
46. |
秦霞, 田利, 李惠玲, 等. 內科住院病人發生靜脈血栓栓塞癥危險因素的 Meta 分析. 現代預防醫學, 2018, 45(4): 753-756.
|
47. |
姚文, 王小玲, 鞏樹梅, 等. 腦出血患者深靜脈血栓形成危險因素的系統評價. 中國護理管理, 2019, 19(9): 1322-1329.
|
48. |
Li J, Wang D, Wang W, et al. In-hospital venous thromboembolism is associated with poor outcome in patients with spontaneous intracerebral hemorrhage: a multicenter, prospective study. J Stroke Cerebrovasc Dis, 2020, 29(8): 104958.
|
49. |
Wijdicks EF, Scott JP. Pulmonary embolism associated with acute stroke. Mayo Clin Proc, 1997, 72(4): 297-300.
|
50. |
國際血管聯盟中國分部護理專業委員會. 住院患者靜脈血栓栓塞癥預防護理與管理專家共識. 解放軍護理雜志, 2021, 38(6): 17-21.
|
51. |
Guyatt GH, Akl EA, Crowther M, et al. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, 141(2 Suppl): 7S-47S.
|
52. |
全國肺栓塞和深靜脈血栓形成防治能力建設項目專家委員會《醫院內靜脈血栓栓塞癥防治質量評價與管理指南(2022 版)》編寫專家組. 醫院內靜脈血栓栓塞癥防治質量評價與管理指南(2022 版). 中華醫學雜志, 2022, 102(42): 3338-3348.
|
53. |
陳熙, 趙玲玲, 張曉娟, 等. 住院患者靜脈血栓栓塞癥風險感知的研究進展. 護理實踐與研究, 2024, 21(2): 249-254.
|
54. |
Fernando SM, Qureshi D, Talarico R, et al. Intracerebral hemorrhage incidence, mortality, and association with oral anticoagulation use: a population study. Stroke, 2021, 52(5): 1673-1681.
|
55. |
Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke, 2022, 53(7): e282-e361.
|
56. |
Ianosi B, Gaasch M, Rass V, et al. Early thrombosis prophylaxis with enoxaparin is not associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage. Eur J Neurol, 2019, 26(2): 333-341.
|
57. |
Pan X, Li J, Xu L, et al. Safety of prophylactic heparin in the prevention of venous thromboembolism after spontaneous intracerebral hemorrhage: a meta-analysis. J Neurol Surg A Cent Eur Neurosurg, 2020, 81(3): 253-260.
|
58. |
蔡奇宴. 顱內出血繼發肺血栓栓塞癥患者的真實世界研究. 重慶: 重慶醫科大學, 2022.
|